Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy P Feldman

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
ERJ Open Research|March 16, 2023
AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants: a phase 1 single and multiple ascending dose studyHunter Gillies, Ralph Niven, Benjamin T Dake, et al.
Pulmonary Circulation|July 7, 2017
Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulationFranck F Rahaghi, Jeremy P Feldman, Roblee P Allen, et al.
Pulmonary Circulation|March 27, 2024
IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertensionHunter Gillies, Murali M Chakinala, Benjamin T Dake, et al.
Pulmonary Circulation|November 15, 2019
Long-term results of the DelIVery for Pulmonary Arterial Hypertension trialMardi Gomberg-Maitland, Robert C Bourge, Shelley M Shapiro, et al.
Chest|July 12, 2016
Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH TrialRobert C Bourge, Aaron B Waxman, Mardi Gomberg-Maitland, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertensionNicholas S Hill, Hunter Gillies, Murali M Chakinala, et al.
Chest|June 7, 2017
Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation ProcedureAaron B Waxman, Hugh T McElderry, Mardi Gomberg-Maitland, et al.
Pulmonary Circulation|October 21, 2021
Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)Jasleen Minhas, Sai Prasanna Narasimmal, Todd M Bull, et al.
Pulmonary Circulation|December 21, 2022
Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association RegistryHilary M DuBrock, Charles D Burger, Sonja D Bartolome, et al.
Pulmonary Circulation|June 23, 2021
Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association RegistryHilary M DuBrock, Charles D Burger, Sonja D Bartolome, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
ERJ Open Research|March 16, 2023
AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants: a phase 1 single and multiple ascending dose studyHunter Gillies, Ralph Niven, Benjamin T Dake, et al.
Pulmonary Circulation|July 7, 2017
Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulationFranck F Rahaghi, Jeremy P Feldman, Roblee P Allen, et al.
Pulmonary Circulation|March 27, 2024
IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertensionHunter Gillies, Murali M Chakinala, Benjamin T Dake, et al.
Pulmonary Circulation|November 15, 2019
Long-term results of the DelIVery for Pulmonary Arterial Hypertension trialMardi Gomberg-Maitland, Robert C Bourge, Shelley M Shapiro, et al.
Chest|July 12, 2016
Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH TrialRobert C Bourge, Aaron B Waxman, Mardi Gomberg-Maitland, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertensionNicholas S Hill, Hunter Gillies, Murali M Chakinala, et al.
Chest|June 7, 2017
Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation ProcedureAaron B Waxman, Hugh T McElderry, Mardi Gomberg-Maitland, et al.
Pulmonary Circulation|October 21, 2021
Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)Jasleen Minhas, Sai Prasanna Narasimmal, Todd M Bull, et al.
Pulmonary Circulation|December 21, 2022
Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association RegistryHilary M DuBrock, Charles D Burger, Sonja D Bartolome, et al.
Pulmonary Circulation|June 23, 2021
Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association RegistryHilary M DuBrock, Charles D Burger, Sonja D Bartolome, et al.
Pageof 2